Opendata, web and dolomites

Solve-RD SIGNED

Solving the unsolved Rare Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Solve-RD" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.solve-rd.eu
 Total cost 15˙361˙621 €
 EC max contribution 15˙361˙621 € (100%)
 Programme 1. H2020-EU.3.1.1. (Understanding health, wellbeing and disease)
 Code Call H2020-SC1-2017-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 2˙753˙262.00
2    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 4˙690˙345.00
3    FUNDACIO CENTRE DE REGULACIO GENOMICA ES (BARCELONA) participant 1˙505˙131.00
4    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 1˙112˙003.00
5    UNIVERSITY OF LEICESTER UK (LEICESTER) participant 937˙500.00
6    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) participant 650˙000.00
7    MANCHESTER UNIVERSITY NHS FOUNDATION TRUST UK (MANCHESTER) participant 435˙900.00
8    UNIVERSITY OF NEWCASTLE UPON TYNE UK (NEWCASTLE UPON TYNE) participant 434˙591.00
9    EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION FR (Paris) participant 375˙000.00
10    CENTRE HOSPITALIER REG UNIVERSITAIRE DIJON FR (DIJON) participant 334˙250.00
11    THE JACKSON LABORATORY NON PROFIT CORPORATION US (BAR HARBOR) participant 334˙137.00
12    UNIVERSITY COLLEGE LONDON UK (LONDON) participant 275˙000.00
13    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 256˙250.00
14    IPATIMUP - INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO PCUP PT (PORTO) participant 250˙000.00
15    UNIVERSITATSKLINIKUM BONN DE (BONN) participant 250˙000.00
16    KING'S COLLEGE LONDON UK (LONDON) participant 187˙824.00
17    SHEFFIELD HALLAM UNIVERSITY UK (SHEFFIELD) participant 140˙675.00
18    UNIVERSITEIT ANTWERPEN BE (ANTWERPEN) participant 131˙250.00
19    EUROPEAN MOLECULAR BIOLOGY LABORATORY DE (HEIDELBERG) participant 125˙000.00
20    UNIVERSITA DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI IT (CASERTA) participant 75˙000.00
21    UNIVERSITA DEGLI STUDI DI FERRARA IT (FERRARA) participant 56˙250.00
22    UNIVERZITA KARLOVA CZ (PRAHA 1) participant 52˙250.00
23    CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST UK (MANCHESTER) participant 0.00

Map

 Project objective

The main ambitions of the Solve-RD proposal are (i) to solve large numbers of RD, for which a molecular cause is not known yet, by sophisticated combined Omics approaches, and (ii) to improve diagnostics of RD patients through a “genetic knowledge web”. Solve-RD will pursue a clear visionary and integrated “beyond the exome” approach. The entire Solve-RD proposal has been motivated, designed and put together by a core group of four ERNs, but also reaches out to all 24 ERNs. To tackle diseases which are unsolved by applying cutting edge strategies, Solve-RD has thus formed a consortium that comprises (i) leading clinicians, geneticists and translational researchers of these ERNs, (ii) RD research and diagnostic infrastructures, (iii) patient organisations, as well as (iv) leading experts in the field of -omics technologies, bioinformatics and knowledge management. Solve-RD will deliver 7 main implementation steps: (i) Collect Phenotypes, (ii) New phenotype patterns, (iii) Re-analyse exomes / genomes, (iv) Novel molecular strategies, (v) Functional analysis, (iv) Clinical utility and (vii) Towards therapy. For analysis Solve-RD will apply data driven and expert driven approaches. We anticipate to increase diagnostic yield from 19.000 unsolved exomes/genomes by about 3-5%. Cohort specific innovative -omis strategies will be pursued, also addressing cost-effective issues. Analysis of more than 800 patients with highly peculiar (ultra-rare) phenotypes will highly increase the chance to find novel disease genes and novel disease mechanisms. We anticipate to solve more than 2.000 cases. Finding further matching patients will be secured by newly developed matchmaking approaches and by screening using MIPs technology in the more than 20.000 unclassified patients of the ERNs. For the first time in Europe we will also implement a novel brokerage structure connecting clinicians, gene discoverer and basic researcher to quickly verify novel genes and disease mechanisms.

 Deliverables

List of deliverables.
Guidelines for collection of experimental data Documents, reports 2020-03-24 14:33:15
Solve-RD communication and dissemination tools Documents, reports 2020-03-24 14:33:15
All foundational standards selected and implemented across the project Documents, reports 2020-03-24 14:33:15
Central RD-Connect database serving Solve-RD, including user authentication and authorization Documents, reports 2020-03-24 14:33:15
Metadata catalog operational, with initial content Documents, reports 2020-03-24 14:33:15
Deployment of PhenoTips custom forms according to the ERNs specifications Documents, reports 2020-03-24 14:33:15
Guidelines for exome/genome re-analysis Documents, reports 2020-03-24 14:33:15
Training modules, guidance document and online help module for collection of phenotypes Documents, reports 2020-03-24 14:33:15
First training for ePAGs delivered Documents, reports 2020-03-24 14:33:14

Take a look to the deliverables list in detail:  detailed list of Solve-RD deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Christian Gagliardi, Federico Perfetto, Massimiliano Lorenzini, Alessandra Ferlini, Fabrizio Salvi, Agnese Milandri, Cristina Candida Quarta, Giulia Taborchi, Simone Bartolini, Sabrina Frusconi, Raffaele Martone, Michele Mario Cinelli, Serena Foffi, Maria Letizia Bacchi Reggiani, Gioele Fabbri, Paolo Cataldo, Francesco Cappelli, Claudio Rapezzi
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure
published pages: 1417-1425, ISSN: 1388-9842, DOI: 10.1002/ejhf.1285
European Journal of Heart Failure 20/10 2020-03-24
2019 Stefania Bigoni, Marcella Neri, Chiara Scotton, Roberto Farina, Patrizia Sabatelli, Chongyi Jiang, Jianguo Zhang, Maria Sofia Falzarano, Rachele Rossi, Davide Ognibene, Rita Selvatici, Francesca Gualandi, Dieter Bosshardt, Paolo Perri, Claudio Campa, Francesco Brancati, Marco Salvatore, Maria Chiara De Stefano, Domenica Taruscio, Leonardo Trombelli, Mingyan Fang, Alessandra Ferlini
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family
published pages: , ISSN: 1664-8021, DOI: 10.3389/fgene.2018.00723
Frontiers in Genetics 9 2020-03-24
2019 Peer Arts, Annet Simons, Mofareh S. AlZahrani, Elanur Yilmaz, Eman AlIdrissi, Koen J. van Aerde, Njood Alenezi, Hamza A. AlGhamdi, Hadeel A. AlJubab, Abdulrahman A. Al-Hussaini, Fahad AlManjomi, Alaa B. Alsaad, Badr Alsaleem, Abdulrahman A. Andijani, Ali Asery, Walid Ballourah, Chantal P. Bleeker-Rovers, Marcel van Deuren, Michiel van der Flier, Erica H. Gerkes, Christian Gilissen, Murad K. Habazi
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies
published pages: , ISSN: 1756-994X, DOI: 10.1186/s13073-019-0649-3
Genome Medicine 11/1 2020-03-24
2018 Annemieke Aartsma-Rus, Alessandra Ferlini, Elizabeth M. McNally, Pietro Spitali, H. Lee Sweeney, Annemieke M. Aartsma-Rus, Christina Al-Khalili Szigyarto, Luca Bello, Abby Bronson, Kristy Brown, Filippo Buccella, Jessica Chadwick, Alessandra Ferlini, Diane Frank, Eric Hoffman, Jane Larkindale, G. McClorey, Elizabeth McNally, Rick Munschauer, Francesco Muntoni, Jane Owens, Ulrike Schara, Pietro Spi
226th ENMC International Workshop:
published pages: 77-86, ISSN: 0960-8966, DOI: 10.1016/j.nmd.2017.10.002
Neuromuscular Disorders 28/1 2020-03-24
2018 Nathalie Goemans, Eugenio Mercuri, Elena Belousova, Hirofumi Komaki, Alberto Dubrovsky, Craig M. McDonald, John E. Kraus, Afrodite Lourbakos, Zhengning Lin, Giles Campion, Susanne X. Wang, Craig Campbell, A. Araujo, E. Bertini, P. Born, C. Cances, B. Chabrol, J.-H. Chae, J. Colomer Oferil, G.P. Comi, J.-M. Cuisset, G. D\'Anjou, I. Desguerre, R. Erazo Torricelli, R. Escobar, D. Feder, A. Ferlini, R.
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
published pages: 4-15, ISSN: 0960-8966, DOI: 10.1016/j.nmd.2017.10.004
Neuromuscular Disorders 28/1 2020-03-24
2019 M. Di Rienzo, M. Antonioli, C. Fusco, Y. Liu, M. Mari, I. Orhon, G. Refolo, F. Germani, M. Corazzari, A. Romagnoli, F. Ciccosanti, B. Mandriani, M. T. Pellico, R. De La Torre, H. Ding, M. Dentice, M. Neri, A. Ferlini, F. Reggiori, M. Kulesz-Martin, M. Piacentini, G. Merla, G. M. Fimia
Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains
published pages: eaau8857, ISSN: 2375-2548, DOI: 10.1126/sciadv.aau8857
Science Advances 5/5 2020-03-24
2019 Tuomo Mantere, Simone Kersten, Alexander Hoischen
Long-Read Sequencing Emerging in Medical Genetics
published pages: , ISSN: 1664-8021, DOI: 10.3389/fgene.2019.00426
Frontiers in Genetics 10 2020-03-24
2018 Fawn Leigh, Alessandra Ferlini, Doug Biggar, Katharine Bushby, Richard Finkel, Lauren P. Morgenroth, Kathryn R. Wagner
Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy
published pages: S5-S16, ISSN: 0031-4005, DOI: 10.1542/peds.2018-0333c
Pediatrics 142/Supplement 2 2020-03-24
2019 Véronique Bolduc, A. Reghan Foley, Herimela Solomon-Degefa, Apurva Sarathy, Sandra Donkervoort, Ying Hu, Grace S. Chen, Katherine Sizov, Matthew Nalls, Haiyan Zhou, Sara Aguti, Beryl B. Cummings, Monkol Lek, Taru Tukiainen, Jamie L. Marshall, Oded Regev, Dina Marek-Yagel, Anna Sarkozy, Russell J. Butterfield, Cristina Jou, Cecilia Jimenez-Mallebrera, Yan Li, Corine Gartioux, Kamel Mamchaoui, Val
A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies
published pages: , ISSN: 2379-3708, DOI: 10.1172/jci.insight.124403
JCI Insight 4/6 2020-03-24
2018 Monika Hiller, Maria Sofia Falzarano, Iker Garcia-Jimenez, Valentina Sardone, Ruurd C. Verheul, Linda Popplewell, Karen Anthony, Estibaliz Ruiz-Del-Yerro, Hana Osman, Jelle J. Goeman, Kamel Mamchaoui, George Dickson, Alessandra Ferlini, Francesco Muntoni, Annemieke Aartsma-Rus, Virginia Arechavala-Gomeza, Nicole A. Datson, Pietro Spitali
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
published pages: e0204485, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0204485
PLOS ONE 13/10 2020-03-24
2018 Eline M. C. Hamilton, Hannemieke D. W. van der Lei, Gerre Vermeulen, Jan A. M. Gerver, Charles M. Lourenço, Sakkubai Naidu, Hanna Mierzewska, Reinoud J. B. J. Gemke, Henrica C. W. de Vet, Bernard M. J. Uitdehaag, Birgit I. Lissenberg-Witte, Marjo S. van der Knaap
Natural History of Vanishing White Matter
published pages: 274-288, ISSN: 0364-5134, DOI: 10.1002/ana.25287
Annals of Neurology 84/2 2020-03-24
2019 Annemieke Aartsma-Rus, Madhuri Hegde, Tawfeg Ben-Omran, Filippo Buccella, Alessandra Ferlini, Pia Gallano, R. Rodney Howell, France Leturcq, Ann S. Martin, Anna Potulska-Chromik, Jonas A. Saute, Wolfgang M. Schmidt, Thomas Sejersen, Sylvie Tuffery-Giraud, Zehra Oya Uyguner, Luci A. Witcomb, Shu Yau, Stanley F. Nelson
Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy
published pages: 305-313.e14, ISSN: 0022-3476, DOI: 10.1016/j.jpeds.2018.10.043
The Journal of Pediatrics 204 2020-03-24
2019 Rachel Thompson, Anastasios Papakonstantinou Ntalis, Sergi Beltran, Ana Töpf, Eduardo de Paula Estephan, Kiran Polavarapu, Peter A. C. ’t Hoen, Paolo Missier, Hanns Lochmüller
Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder
published pages: , ISSN: 1059-7794, DOI: 10.1002/humu.23792
Human Mutation 2020-03-24
2018 Sebastian Köhler, Leigh Carmody, Nicole Vasilevsky, Julius O B Jacobsen, Daniel Danis, Jean-Philippe Gourdine, Michael Gargano, Nomi L Harris, Nicolas Matentzoglu, Julie A McMurry, David Osumi-Sutherland, Valentina Cipriani, James P Balhoff, Tom Conlin, Hannah Blau, Gareth Baynam, Richard Palmer, Dylan Gratian, Hugh Dawkins, Michael Segal, Anna C Jansen, Ahmed Muaz, Willie H Chang, Jenna Bergers
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
published pages: D1018-D1027, ISSN: 0305-1048, DOI: 10.1093/nar/gky1105
Nucleic Acids Research 47/D1 2020-03-24
2019 Jingxia Wu, Sicong Ma, Roger Sandhoff, Yanan Ming, Agnes Hotz-Wagenblatt, Vincent Timmerman, Nathalie Bonello-Palot, Beate Schlotter-Weigel, Michaela Auer-Grumbach, Pavel Seeman, Wolfgang N. Löscher, Markus Reindl, Florian Weiss, Eric Mah, Nina Weisshaar, Alaa Madi, Kerstin Mohr, Tilo Schlimbach, Rubí M.-H. Velasco Cárdenas, Jonas Koeppel, Florian Grünschläger, Lisann Müller, Maren Baumeiste
Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness
published pages: 1218-1231.e5, ISSN: 1074-7613, DOI: 10.1016/j.immuni.2019.03.005
Immunity 50/5 2020-03-24
2019 Rachel Thompson, Gisèle Bonne, Paolo Missier, Hanns Lochmüller
Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
published pages: 19-37, ISSN: 2397-8554, DOI: 10.1042/etls20180100
Emerging Topics in Life Sciences 3/1 2020-03-24
2019 Luciano Merlini, Patrizia Sabatelli, Manuela Antoniel, Valeria Carinci, Fabio Niro, Giuseppe Monetti, Annalaura Torella, Teresa Giugliano, Cesare Faldini, Vincenzo Nigro
Congenital myopathy with hanging big toe due to homozygous myopalladin (MYPN) mutation
published pages: , ISSN: 2044-5040, DOI: 10.1186/s13395-019-0199-9
Skeletal Muscle 9/1 2020-03-24
2019 Liena E. O. Elsayed, Isra Z. M. Eltazi, Ammar E. M. Ahmed, Giovanni Stevanin
Hereditary spastic paraplegias: time for an objective case definition and a new nosology for neurogenetic disorders to facilitate biomarker/therapeutic studies
published pages: 409-415, ISSN: 1473-7175, DOI: 10.1080/14737175.2019.1608824
Expert Review of Neurotherapeutics 19/5 2020-03-24
2019 María-Jesús Sobrido, Peter Bauer, Tom de Koning, Thomas Klopstock, Yann Nadjar, Marc C Patterson, Matthis Synofzik, Chris J Hendriksz
Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?
published pages: , ISSN: 1750-1172, DOI: 10.1186/s13023-018-0985-1
Orphanet Journal of Rare Diseases 14/1 2020-03-24
2019 Giulia Coarelli, Rebecca Schule, Bart P.C. van de Warrenburg, Peter De Jonghe, Claire Ewenczyk, Andrea Martinuzzi, Matthis Synofzik, Elisa G. Hamer, Jonathan Baets, Mathieu Anheim, Ludger Schöls, Tine Deconinck, Pegah Masrori, Bertrand Fontaine, Thomas Klockgether, Maria Grazia D\'Angelo, Marie-Lorraine Monin, Jan De Bleecker, Isabelle Migeotte, Perrine Charles, Maria Teresa Bassi, Thomas Klopstoc
Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7
published pages: e2679-e2690, ISSN: 0028-3878, DOI: 10.1212/wnl.0000000000007606
Neurology 92/23 2020-03-24
2019 Aleksandra Siekierska, Hannah Stamberger, Tine Deconinck, Stephanie N. Oprescu, Michèle Partoens, Yifan Zhang, Jo Sourbron, Elias Adriaenssens, Patrick Mullen, Patrick Wiencek, Katia Hardies, Jeong-Soo Lee, Hoi-Khoanh Giong, Felix Distelmaier, Orly Elpeleg, Katherine L. Helbig, Joseph Hersh, Sedat Isikay, Elizabeth Jordan, Ender Karaca, Angela Kecskes, James R. Lupski, Reka Kovacs-Nagy, Patrick M
Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-018-07953-w
Nature Communications 10/1 2020-03-24
2019 Mohammad Ali Farazi Fard, Adriana P. Rebelo, Elena Buglo, Hamid Nemati, Hassan Dastsooz, Ina Gehweiler, Selina Reich, Jennifer Reichbauer, Beatriz Quintáns, Andrés Ordóñez-Ugalde, Andrea Cortese, Steve Courel, Lisa Abreu, Eric Powell, Matt C. Danzi, Nicole B. Martuscelli, Dana M. Bis-Brewer, Feifei Tao, Fariba Zarei, Parham Habibzadeh, Majid Yavarian, Farzaneh Modarresi, Mohammad Silawi, Zahra
Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia
published pages: 767-773, ISSN: 0002-9297, DOI: 10.1016/j.ajhg.2019.03.001
The American Journal of Human Genetics 104/4 2020-03-24
2019 Mansour Haidar, Bob Asselbergh, Elias Adriaenssens, Vicky De Winter, Jean-Pierre Timmermans, Michaela Auer-Grumbach, Manisha Juneja, Vincent Timmerman
Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies
published pages: 1051-1068, ISSN: 1554-8627, DOI: 10.1080/15548627.2019.1569930
Autophagy 15/6 2020-03-24
2018 Rachel Thompson, Angela Abicht, David Beeson, Andrew G. Engel, Bruno Eymard, Emmanuel Maxime, Hanns Lochmüller
A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era
published pages: , ISSN: 1750-1172, DOI: 10.1186/s13023-018-0955-7
Orphanet Journal of Rare Diseases 13/1 2020-03-24
2019 Maxime Boutry, Sara Morais, Giovanni Stevanin
Update on the Genetics of Spastic Paraplegias
published pages: , ISSN: 1528-4042, DOI: 10.1007/s11910-019-0930-2
Current Neurology and Neuroscience Reports 19/4 2020-03-24
2018 Ashraf Yahia, Liena Elsayed, Arwa Babai, Mustafa A. Salih, Sarah Misbah El-Sadig, Mutaz Amin, Mahmoud Koko, Rayan Abubakr, Razaz Idris, Shaimaa Omer M.A. Taha, Salah A. Elmalik, Alexis Brice, Ammar Eltahir Ahmed, Giovanni Stevanin
Intra-familial phenotypic heterogeneity in a Sudanese family with DARS2-related leukoencephalopathy, brainstem and spinal cord involvement and lactate elevation: a case report
published pages: , ISSN: 1471-2377, DOI: 10.1186/s12883-018-1180-7
BMC Neurology 18/1 2020-03-24
2018 Sebastian Köhler
Improved ontology-based similarity calculations using a study-wise annotation model
published pages: , ISSN: 1758-0463, DOI: 10.1093/database/bay026
Database 2018/1 2020-03-24
2019 Judith E. Grolleman, Marcos Díaz-Gay, Sebastià Franch-Expósito, Sergi Castellví-Bel, Richarda M. de Voer
Somatic mutational signatures in polyposis and colorectal cancer
published pages: , ISSN: 0098-2997, DOI: 10.1016/j.mam.2019.05.002
Molecular Aspects of Medicine 2020-03-24
2019 Maria Sofia Falzarano, Alessandra Ferlini
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature
published pages: 627, ISSN: 2077-0383, DOI: 10.3390/jcm8050627
Journal of Clinical Medicine 8/5 2020-03-24
2019 Daniela Hombach, Jana M. Schwarz, Ellen Knierim, Markus Schuelke, Dominik Seelow, Sebastian Köhler
Phenotero: Annotate as you write
published pages: 287-292, ISSN: 0009-9163, DOI: 10.1111/cge.13471
Clinical Genetics 95/2 2020-03-24
2019 Jana Marie Schwarz, Daniela Hombach, Sebastian Köhler, David N Cooper, Markus Schuelke, Dominik Seelow
RegulationSpotter: annotation and interpretation of extratranscriptic DNA variants
published pages: W106-W113, ISSN: 0305-1048, DOI: 10.1093/nar/gkz327
Nucleic Acids Research 47/W1 2020-03-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOLVE-RD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOLVE-RD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.1.)

DECISION (2020)

DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

Read More  

BIND (2020)

Brain Involvement iN Dystrophinopathies

Read More  

DC-ren (2020)

Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

Read More